The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
IL-6/IL-6 receptor system and its role in physiological and pathological conditions
Abstract
IL (interleukin)-6, which was originally identified as a B-cell differentiation factor, is a multifunctional cytokine that regulates the immune response, haemopoiesis, the acute phase response and inflammation. IL-6 is produced by various types of cell and influences various cell types, and has multiple biological activities through its unique receptor system. IL-6 exerts its biological activities through two molecules: IL-6R (IL-6 receptor) and gp130. When IL-6 binds to mIL-6R (membrane-bound form of IL-6R), homodimerization of gp130 is induced and a high-affinity functional receptor complex of IL-6, IL-6R and gp130 is formed. Interestingly, sIL-6R (soluble form of IL-6R) also binds with IL-6, and the IL-6–sIL-6R complex can then form a complex with gp130. The homodimerization of receptor complex activates JAKs (Janus kinases) that then phosphorylate tyrosine residues in the cytoplasmic domain of gp130. The gp130-mediated JAK activation by IL-6 triggers two main signalling pathways: the gp130 Tyr759-derived SHP-2 (Src homology 2 domain-containing protein tyrosine phosphatase-2)/ERK (extracellular-signal-regulated kinase) MAPK (mitogen-activated protein kinase) pathway and the gp130 YXXQ-mediated JAK/STAT (signal transducer and activator of transcription) pathway. Increased IL-6 levels are observed in several human inflammatory diseases, such as rheumatoid arthritis, Castleman's disease and systemic juvenile idiopathic arthritis. IL-6 is also critically involved in experimentally induced autoimmune diseases. All clinical findings and animal models suggest that IL-6 plays a number of critical roles in the pathogenesis of autoimmune diseases. In the present review, we first summarize the IL-6/IL-6R system and IL-6 signal transduction, and then go on to discuss the physiological and pathological roles of IL-6.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Smolen, J. S., Beaulieu, A., Rubbert-Roth, A., Ramos-Remus, C., Rovensky, J., Alecock, E., Woodworth, T., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60453-5 · Cited by 1,399
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Emery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092932 · Cited by 1,104
New insights into the regulation of T cells by γc family cytokines
Rochman, Y., Spolski, R., & Leonard, W. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2580 · Cited by 1,053
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1431 · Cited by 1,019
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
Dillon, S. R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S. R., Haugen, H. S., Maurer, M., Harder, B., Johnston, J., et al. (2004) · Nature Immunology · doi:10.1038/ni1084 · Cited by 1,015
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease
Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., & Komori, T. (1989) · Blood · doi:10.1182/blood.v74.4.1360.1360 · Cited by 928
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
The two faces of IL-6 on Th1/Th2 differentiation
Diehl, S., & Rincón, M. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00210-9 · Cited by 872
Genovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23940 · Cited by 855
Jones, G., Sebba, A., Gu, J., Lowenstein, M. B., Calvo, A., Gomez-Reino, J. J., Siri, D. A., Tomšič, M., Alecock, E., Woodworth, T., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.105197 · Cited by 797
Maini, R. N., Taylor, P. C., Szechinski, J., Pavelka, K., Bröll, J., Balint, G., Emery, P., Raemen, F., Petersen, J., Smolen, J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22033 · Cited by 790
Yokota, S., Imagawa, T., Mori, M., Miyamae, T., Aihara, Y., Takei, S., Iwata, N., Umebayashi, H., Murata, T., Miyoshi, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60454-7 · Cited by 789
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Muraguchi, A., Hirano, T., Tang, B., Matsuda, T., Horii, Y., Nakajima, K., & Kishimoto, T. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.332 · Cited by 783
Interleukin-6 stimulates lipolysis and fat oxidation in humans
van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Møller, K., Saltin, B., Febbraio, M. A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021687 · Cited by 767
Klein, B., Zhang, X., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M., & Bataille, R. (1989) · Blood · doi:10.1182/blood.v73.2.517.517 · Cited by 763
Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease
Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4602 · Cited by 754
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
Nishimoto, N., Hashimoto, J., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Murata, N., van der Heijde, D., & Kishimoto, T. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068064 · Cited by 727
Shimomura, I., Bashmakov, Y., & Horton, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30028 · Cited by 708
WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27
Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H., McClanahan, T. K., de Waal Malefyt, R., & Kastelein, R. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2225 · Cited by 695
Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex
Boulanger, M. J., Chow, D.-C., Brevnova, E. E., & Garcia, K. C. (2003) · Science · doi:10.1126/science.1083901 · Cited by 642
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
Krzystolik, M. G. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.3.338 · Cited by 590
IgG1 plasmacytosis in interleukin 6 transgenic mice
Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., & Kishimoto, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7547 · Cited by 586
Wipke, B. T., & Allen, P. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1601 · Cited by 585
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
De Benedetti, F., Alonzi, T., Moretta, A., Lazzaro, D., Costa, P., Poli, V, Martini, A., Ciliberto, G., & Fattori, E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119207 · Cited by 529
B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes.
Lotz, M., Jirik, F., Kabouridis, P., Tsoukas, C., Hirano, T., Kishimoto, T., & Carson, D. A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.1253 · Cited by 527
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T., & Yoshizaki, K. (2000) · Blood · doi:10.1182/blood.v95.1.56 · Cited by 441
Dienz, O., Eaton, S. M., Bond, J. P., Neveu, W., Moquin, D., Noubade, R., Briso, E. M., Charland, C., Leonard, W. J., Ciliberto, G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081571 · Cited by 439
Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer
Bachmann, J., Heiligensetzer, M., Krakowski-Roosen, H., Büchler, M. W., Friess, H., & Martignoni, M. E. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0505-z · Cited by 428
Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas
Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Sonoda, T., Hirano, T., & Kishimoto, T. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80805-1 · Cited by 411
Kremer, J. M., Blanco, R., Brzosko, M., Burgos-Vargas, R., Halland, A.-M., Vernon, E., Ambs, P., & Fleischmann, R. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30158 · Cited by 409
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
Ogata, A., Chauhan, D., Teoh, G., Treon, S. P., Urashima, M., Schlossman, R. L., & Anderson, K. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.5.2212 · Cited by 399
Nakahara, H., Song, J., Sugimoto, M., Hagihara, K., Kishimoto, T., Yoshizaki, K., & Nishimoto, N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11143 · Cited by 395
ADLER, H. L., McCURDY, M. A., KATTAN, M. W., TIMME, T. L., SCARDINO, P. T., & THOMPSON, T. C. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)62092-5 · Cited by 386
Interleukin-6 in bone metastasis and cancer progression
Ara, T., & DeClerck, Y. A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.026 · Cited by 379
Signaling mechanisms through gp130: A model of the cytokine system
Hirano, T., Nakajima, K., & Hibi, M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)80005-1 · Cited by 370
Seddon, J. M. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.6.774 · Cited by 354
Hirano, T., Taga, T., Yasukawa, K., Nakajima, K., Nakano, N., Takatsuki, F., Shimizu, M., Murashima, A., Tsunasawa, S., & Sakiyama, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.228 · Cited by 351
Serada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., Yoshida, H., Nishikawa, T., Terabe, F., Ohkawara, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802218105 · Cited by 349
Self-citationHashizume, M., Hayakawa, N., & Mihara, M. (2008) · Rheumatology · doi:10.1093/rheumatology/ken363 · Cited by 347
Self-citationFever and hypothermia in systemic inflammation: recent discoveries and revisions
Romanovsky, A. (2005) · Frontiers in Bioscience · doi:10.2741/1690 · Cited by 344
Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.1120 · Cited by 343
Madhok, R., Crilly, A., Watson, J., & Capell, H. A. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.3.232 · Cited by 340
Structural analysis of the sequence coding for an inducible 26‐kDa protein in human fibroblasts
HAEGEMAN, G., CONTENT, J., VOLCKAERT, G., DERYNCK, R., TAVERNIER, J., & FIERS, W. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09931.x · Cited by 337
Nishimoto, N., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Azuma, J., & Kishimoto, T. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0125-1 · Cited by 334
Mihara, M., Kasutani, K., Okazaki, M., Nakamura, A., Kawai, S., Sugimoto, M., Matsumoto, Y., & Ohsugi, Y. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.05.010 · Cited by 328
Self-citationO'Brien, C. A., Gubrij, I., Lin, S.-C., Saylors, R. L., & Manolagas, S. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19301 · Cited by 313
Petersen, E. W., Carey, A. L., Sacchetti, M., Steinberg, G. R., Macaulay, S. L., Febbraio, M. A., & Pedersen, B. K. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2004 · Cited by 311
Taga, T., Kawanishi, Y., Hardy, R. R., Hirano, T., & Kishimoto, T. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.967 · Cited by 310
Rivera, S., Nemeth, E., Gabayan, V., Lopez, M. A., Farshidi, D., & Ganz, T. (2005) · Blood · doi:10.1182/blood-2005-04-1766 · Cited by 308
Collagen Type II-Specific Monoclonal Antibody-Induced Arthritis in Mice
Nandakumar, K. S., Svensson, L., & Holmdahl, R. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63542-0 · Cited by 294
Yoshitake, F., Itoh, S., Narita, H., Ishihara, K., & Ebisu, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m607999200 · Cited by 291
Nishimoto, N., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Azuma, J., & Kishimoto, T. (2009) · Modern Rheumatology · doi:10.3109/s10165-008-0125-1 · Cited by 268
Interleukin-6 and prostate cancer progression
SMITH, P., HOBISCH, A., LIN, D., CULIG, Z., & KELLER, E. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00021-6 · Cited by 264
Averting inflammation by targeting the cytokine environment
Kopf, M., Bachmann, M. F., & Marsland, B. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2805 · Cited by 257
Interleukin-6 Regulates Human Adipose Tissue Lipid Metabolism and Leptin Production in Vitro
Trujillo, M. E., Sullivan, S., Harten, I., Schneider, S. H., Greenberg, A. S., & Fried, S. K. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0603 · Cited by 248
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S., Jones, S. A., Rose-John, S., & Scheller, J. (2008) · Blood · doi:10.1182/blood-2007-07-102137 · Cited by 245
Sopasakis, V. R., Sandqvist, M., Gustafson, B., Hammarstedt, A., Schmelz, M., Yang, X., Jansson, P., & Smith, U. (2004) · Obesity Research · doi:10.1038/oby.2004.51 · Cited by 243
The Functional Block of TNF but Not of IL-6 Prevents Bone Loss in Ovariectomized Mice
Kimble, R. B., Bain, S., & Pacifici, R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.6.935 · Cited by 241
Chen, Q., Fisher, D. T., Clancy, K. A., Gauguet, J.-M. M., Wang, W.-C., Unger, E., Rose-John, S., von Andrian, U. H., Baumann, H., & Evans, S. S. (2006) · Nature Immunology · doi:10.1038/ni1406 · Cited by 233
Song, S.-N. J., Tomosugi, N., Kawabata, H., Ishikawa, T., Nishikawa, T., & Yoshizaki, K. (2010) · Blood · doi:10.1182/blood-2010-03-271791 · Cited by 228
Fujimoto, M., Serada, S., Mihara, M., Uchiyama, Y., Yoshida, H., Koike, N., Ohsugi, Y., Nishikawa, T., Ripley, B., Kimura, A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24126 · Cited by 225
Self-citationRole of interleukin 6 in fever in rats
LeMay, L. G., Vander, A. J., & Kluger, M. J. (1990) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1990.258.3.r798 · Cited by 225
Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia
Carson, J. A., & Baltgalvis, K. A. (2010) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3181f44f11 · Cited by 215
Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study
van Gameren, M., Willemse, P., Mulder, N., Limburg, P., Groen, H., Vellenga, E., & de Vries, E. (1994) · Blood · doi:10.1182/blood.v84.5.1434.1434 · Cited by 214
Garnero, P., Thompson, E., Woodworth, T., & Smolen, J. S. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25053 · Cited by 205
Modur, V, Li, Y., Zimmerman, G. A., Prescott, S. M., & McIntyre, T. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119821 · Cited by 204
Ulich, T., del Castillo, J., & Guo, K. (1989) · Blood · doi:10.1182/blood.v73.1.108.108 · Cited by 203
Nishimoto, N., Yoshizaki, K., Maeda, K., Kuritani, T., Deguchi, H., Sato, B., Imai, N., Suemura, M., Kakehi, T., Takagi, N., et al. (2003) · PubMed · Cited by 203
Total cholesterol and LDL levels decrease before rheumatoid arthritis
Myasoedova, E., Crowson, C. S., Kremers, H. M., Fitz-Gibbon, P. D., Therneau, T. M., & Gabriel, S. E. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122374 · Cited by 203
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
Yoshimura, T., Sonoda, K.-H., Ohguro, N., Ohsugi, Y., Ishibashi, T., Cua, D. J., Kobayashi, T., Yoshida, H., & Yoshimura, A. (2009) · Rheumatology · doi:10.1093/rheumatology/ken489 · Cited by 196
Self-citationHuman β 2 Interferon and B-Cell Differentiation Factor BSF-2 Are Identical
Sehgal, P. B., May, L. T., Tamm, I., & Vilček, J. (1987) · Science · doi:10.1126/science.3492764 · Cited by 195
Serum amyloid A (SAA): Biochemistry, genetics and the pathogenesis of AA amyloidosis
Husby, G., Marhaug, G., Dowtor, B., Sletten, K., & Sipe, J. D. (1994) · Amyloid · doi:10.3109/13506129409148635 · Cited by 193
Schwarze, M. M., & Hawley, R. G. (1995) · PubMed · Cited by 189
Molecular and cellular biology of interleukin-6 and its receptor
Keller, E. T. (1996) · Frontiers in Bioscience · doi:10.2741/a136 · Cited by 182
Properties and origin of human Th17 cells
Romagnani, S., Maggi, E., Liotta, F., Cosmi, L., & Annunziato, F. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.12.019 · Cited by 180
Nowell, M. A., Richards, P. J., Fielding, C. A., Ognjanovic, S., Topley, N., Williams, A. S., Bryant‐Greenwood, G., & Jones, S. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21942 · Cited by 178
Park, Y.-B., Choi, H. K., Kim, M.-Y., Lee, W.-K., Song, J., Kim, D.-K., & Lee, S.-K. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01186-5 · Cited by 176
B-cell-directed therapies for autoimmune disease
Dörner, T., Radbruch, A., & Burmester, G. R. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.141 · Cited by 175
Ara, T., Song, L., Shimada, H., Keshelava, N., Russell, H. V., Metelitsa, L. S., Groshen, S. G., Seeger, R. C., & DeClerck, Y. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0613 · Cited by 175
Goydos, J. S., Brumfield, A., Frezza, E., Booth, A., Lotze, M., & Carty, S. (1998) · Annals of Surgery · doi:10.1097/00000658-199803000-00012 · Cited by 160
IL‐6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice
Mihara, Takagi, Takeda, & Ohsugi (1998) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00612.x · Cited by 155
A key role for G-CSF–induced neutrophil production and trafficking during inflammatory arthritis
Eyles, J. L., Hickey, M. J., Norman, M. U., Croker, B. A., Roberts, A. W., Drake, S. F., James, W. G., Metcalf, D., Campbell, I. K., & Wicks, I. P. (2008) · Blood · doi:10.1182/blood-2008-02-139535 · Cited by 154
Recent developments and complexities in neutrophil transmigration
Woodfin, A., Voisin, M.-B., & Nourshargh, S. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283333930 · Cited by 153
Izumi‐Nagai, K., Nagai, N., Ozawa, Y., Mihara, M., Ohsugi, Y., Kurihara, T., Koto, T., Satofuka, S., Inoue, M., Tsubota, K., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061018 · Cited by 153
Self-citationAnti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
Tanaka, T., Narazaki, M., & Kishimoto, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.023 · Cited by 146
Disturbances in the normal regulation of SREBP-sensitive genes in PPARα-deficient mice
Patel, D. D., Knight, B. L., Wiggins, D. K., Humphreys, S. M., & Gibbons, G. F. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31655-2 · Cited by 142
Iwanami, K., Matsumoto, I., Tanaka-Watanabe, Y., Inoue, A., Mihara, M., Ohsugi, Y., Mamura, M., Goto, D., Ito, S., Tsutsumi, A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23222 · Cited by 138
Self-citationKatsume, A., Saito, H., Yamada, Y., Yorozu, K., Ueda, O., Akamatsu, K.-I., Nishimoto, N., Kishimoto, T., Yoshizaki, K., & Ohsugi, Y. (2002) · Cytokine · doi:10.1006/cyto.2002.2012 · Cited by 134
Regulation of IL-17 in Human CCR6+ Effector Memory T Cells
Liu, H., & Rohowsky‐Kochan, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.7948 · Cited by 133
Kitani, A., HARA, M., HIROSE, T., Harigai, M., SUZUKI, K., Kawakami, M., AWAGUCHI, Y. K., HIDAK, T., Kawagoe, A., & Nakamura, H. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb03042.x · Cited by 131
The acute phase protein response in patients receiving subcutaneous IL-6
Banks, R. E., Forbes, M. A., Storr, M., Higginson, J., Thompson, D., Raynes, J. G., Illingworth, J. M., Perren, T. J., Selby, P. J., & Whicher, J. T. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb06659.x · Cited by 130
Molecular Mechanisms of Castration-Resistant Prostate Cancer Progression
Dutt, S. S., & Gao, A. C. (2009) · Future Oncology · doi:10.2217/fon.09.117 · Cited by 130
Kawashiri, S., Kawakami, A., Yamasaki, S., Imazato, T., Iwamoto, N., Fujikawa, K., Aramaki, T., Tamai, M., Nakamura, H., Ida, H., et al. (2011) · Rheumatology International · doi:10.1007/s00296-009-1303-y · Cited by 129
Interleukin‐6 as a Therapeutic Target in Candidate Inflammatory Diseases
Nishimoto, N. (2010) · Clinical pharmacology and therapy · doi:10.1038/clpt.2009.313 · Cited by 122
Effects of Anti‐TNF‐α Treatment on Lipid Profile in Patients with Active Rheumatoid Arthritis
SERIOLO, B., Paolino, S., Sulli, A., FASCIOLO, D., & Cutolo, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1351.039 · Cited by 121
Silacci, P., Dayer, J., Desgeorges, A., Peter, R. E., Manueddu, C., & Guerne, P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13625 · Cited by 118
SOCS: suppressors of cytokine signalling
Starr, R., & Hilton, D. J. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00067-3 · Cited by 112
IL-6 Type Cytokine Receptor Complexes: Hexamer, Tetramer or Both?
Grötzinger, J., Kernebeck, T., Kallen, K., & Rose‐John, S. (1999) · Biological Chemistry · doi:10.1515/bc.1999.100 · Cited by 111
Chen, Q., Wang, W., Bruce, R., Li, H., Schleider, D. M., Mulbury, M. J., Bain, M. D., Wallace, P. K., Baumann, H., & Evans, S. S. (2004) · Immunity · doi:10.1016/s1074-7613(03)00358-3 · Cited by 110
Characterization of anti-mouse interleukin-6 receptor antibody
Okazaki, M., Yamada, Y., Nishimoto, N., Yoshizaki, K., & Mihara, M. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00202-x · Cited by 108
Self-citationChoi, H. K., & Seeger, J. D. (2005) · PubMed · Cited by 106
Cavarretta, I. T. R., Neuwirt, H., Untergasser, G., Moser, P. L., Zaki, M. H., Steiner, H., Rumpold, H. F., Fuchs, D., Hobisch, A., Nemeth, J. A., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1210097 · Cited by 105
IL-6 plays an essential role in neutrophilia under inflammation
Hashizume, M., Higuchi, Y., Uchiyama, Y., & Mihara, M. (2011) · Cytokine · doi:10.1016/j.cyto.2011.01.007 · Cited by 103
Self-citationChung, T. D., Yu, J. J., Kong, T., Spiotto, M. T., & Lin, J. M. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000101)42:1<1::aid-pros1>3.0.co;2-y · Cited by 102
Rose‐John, S., & Neurath, M. F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00003-2 · Cited by 100
Hashizume, M., Hayakawa, N., Suzuki, M., & Mihara, M. (2009) · Rheumatology International · doi:10.1007/s00296-009-0885-8 · Cited by 92
Self-citationThe therapy of autoimmune diseases by anti-interleukin-6 receptor antibody
Mihara, M., Nishimoto, N., & Ohsugi, Y. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.5.683 · Cited by 88
Self-citationLee, S. O., Chun, J. Y., Nadiminty, N., Lou, W., & Gao, A. C. (2007) · The Prostate · doi:10.1002/pros.20553 · Cited by 87
Schiechl, G., Bauer, B., Fuss, I. J., Lang, S. A., Moser, C., Ruemmele, P., Rose‐John, S., Neurath, M. F., Geissler, E. K., Schlitt, H. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42540 · Cited by 87
Ohe, Y., Podack, E. R., Olsen, K. J., Miyahara, Y., Miura, K., Saitô, H., Koishihara, Y., Ohsugi, Y., Ohira, T., Nishio, K., et al. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.174 · Cited by 79
Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis.
Benedetti, F. D., Pignatti, P., Gerloni, V., Massa, M., Sartirana, P., Caporali, R. F., Montecucco, C., Corti, A., Fantini, F., & Martini, A. (1997) · PubMed · Cited by 79
Hashizume, M., & Mihara, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.135 · Cited by 76
Self-citationFujimoto-Ouchi, K., Tamura, S., Mori, K., Tanaka, Y., & Ishitsuka, H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610416 · Cited by 76
Suzuki, M., Hashizume, M., Yoshida, H., & Mihara, M. (2009) · Rheumatology International · doi:10.1007/s00296-009-0953-0 · Cited by 71
Self-citationHashizume, M., Uchiyama, Y., Horai, N., Tomosugi, N., & Mihara, M. (2010) · Rheumatology International · doi:10.1007/s00296-009-1075-4 · Cited by 70
Self-citationHashizume, M., Yoshida, H., Koike, N., Suzuki, M., & Mihara, M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.104844 · Cited by 68
Self-citationStoyan, T., Michaelis, U., Schooltink, H., DAM, M. V., Rudolph, R., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18138.x · Cited by 67
Weidle, U. H., Klostermann, S., Eggle, D., & Krüger, A. (2010) · PubMed · Cited by 60
Kawashiri, S., Kawakami, A., Iwamoto, N., Fujikawa, K., Aramaki, T., Tamai, M., Arima, K., Kamachi, M., Yamasaki, S., Nakamura, H., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090132 · Cited by 56
Suzuki, M., Hashizume, M., Yoshida, H., Shiina, M., & Mihara, M. (2010) · Cytokine · doi:10.1016/j.cyto.2010.03.017 · Cited by 55
Self-citationHusby, G. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90001-t · Cited by 54
Rose‐John, S., Erich, H. I. P. P., Lenz, D., Legrès, L., Korr, H., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67870-1 · Cited by 52
Uchiyama, Y., Yorozu, K., Hashizume, M., Moriya, Y., & Mihara, M. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1159 · Cited by 50
Self-citationInterleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells
Nakajima, S., Naruto, T., Miyamae, T., Imagawa, T., Mori, M., Nishimaki, S., & Yokota, S. (2009) · Cytokine · doi:10.1016/j.cyto.2009.05.002 · Cited by 50
Changes of cytokines and thyroid function in patients with recurrent breast cancer.
Yokoe, T., Iino, Y., Takei, H., Horiguchi, J., Koibuchi, Y., Maemura, M., Ohwada, S., & Morishita, Y. (1997) · PubMed · Cited by 50
Rigas, J. R., Schuster, M., Орлов, С. В., Milovanović, B., Prabhash, K., Smith, J., & and the ALD518 study group (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.7622 · Cited by 46
Saiki, O., Takao, R., Naruse, Y., Kuhara, M., Imai, S., & Uda, H. (2007) · PubMed · Cited by 46
The effect of interleukin-6 on L-selectin levels on polymorphonuclear leukocytes
Suwa, T., Hogg, J. C., Quinlan, K. B., & van Eeden, S. F. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00185.2002 · Cited by 39
Yoshida, H., Hashizume, M., Suzuki, M., & Mihara, M. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.026 · Cited by 35
Self-citationMartens, A. S., Bode, J. G., Heinrich, P. C., & Graeve, L. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.20.3593 · Cited by 33
Schuster, M., Rigas, J. R., Орлов, С. В., Milovanović, B., Prabhash, K., Smith, J., & and the ALD518 study group (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.7631 · Cited by 30
Hashizume, M., & Mihara, M. (2011) · Inflammation and Regeneration · doi:10.2492/inflammregen.31.325 · Cited by 29
Self-citationSoluble immunological parameters and early prognosis of renal cell cancer patients.
KALLIO, J. P., Tammela, T. L. J., Marttinen, A. T., & Kellokumpu‐Lehtinen, P. (2001) · PubMed · Cited by 25
Mihara, M., Fukui, H., Koishihara, Y., Saito, M., & Ohsugi, Y. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05485.x · Cited by 24
Self-citationTerabe, F., Fujimoto, M., Serada, S., Shinzaki, S., Iijima, H., Tsujii, M., Hayashi, N., Nomura, S., Kawahata, H., Jang, M. H., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21384 · Cited by 17
Self-citationSuzuki, M., Hashizume, M., Yoshida, H., Shiina, M., & Mihara, M. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04276.x · Cited by 16
Self-citationAnemia in monkey collagen-induced arthritis is correlated with serum IL-6, but not TNFα
Uchiyama, Y., Koike, N., & Mihara, M. (2008) · Rheumatology International · doi:10.1007/s00296-008-0547-2 · Cited by 12
Self-citationHashizume, M., & Mihara, M. (2008) · Rheumatology International · doi:10.1007/s00296-008-0703-8 · Cited by 9
Self-citation
Cited by
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654
Pro-inflammatory cytokines: The link between obesity and osteoarthritis
Wang, T., & He, C. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.002 · Cited by 1,034
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
Maude, S. L., Barrett, D., Teachey, D. T., & Grupp, S. A. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000035 · Cited by 752
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
Maude, S. L., Teachey, D. T., Porter, D. L., & Grupp, S. A. (2015) · Blood · doi:10.1182/blood-2014-12-580068 · Cited by 727
Metadata
- Authors
- Mihara, M., Hashizume, M., Yoshida, H., Suzuki, M., & Shiina, M.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2011-10-14
- Volume
- 122
- Issue
- 4
- Pages
- 143-159
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2044596369
- Cited by
- 895
- References
- 162
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.